scPharmaceuticals Inc., a pharmaceutical company, engages in the development and commercialization of various pharmaceutical products. The company's lead product candidate is FUROSCIX that consists of formulation of furosemide, which is delivered through an on-body infusor for treatment of congestion in patients with heart failure. Its product pipeline also includes scCeftriaxone, an antibiotic to treat infections caused by gram-positive and gram-negative organisms; and scCarbapenem program, an antibiotic for treating infections caused by gram-negative organisms. The company has a development agreement with West Pharmaceutical Services, Inc. for development of single use SmartDose device. scPharmaceuticals Inc. was incorporated in 2013 and is headquartered in Burlington, Massachusetts.

首席执行官

Mr. John H. Tucker

员工

162

国家

美国

ISIN

US8106481059

上市

2SX.MU

STU

2SX.STU

0 Comments

分享你的想法

FAQ

Scpharmaceuticals 今天的股价是多少？▼

SCPH 当前价格为 $5.67 USD，过去 24 小时上涨了 +0%。在图表上更密切关注 Scpharmaceuticals 股价表现。

Scpharmaceuticals 的股票代码是什么？▼

根据交易所不同，股票代码可能会有所不同。例如，在 XNAS 交易所，Scpharmaceuticals 的股票以代码 SCPH 进行交易。

Scpharmaceuticals 的股价在上涨吗？▼

SCPH 股票较上周上涨 +0%，本月上涨 +0%，过去一年 Scpharmaceuticals 上涨 +1.61%。

Scpharmaceuticals 去年的营收是多少？▼

Scpharmaceuticals 去年的营收为 36.33MUSD。

Scpharmaceuticals 去年的净利润是多少？▼

SCPH 去年的净收益为 -85.15MUSD。

Scpharmaceuticals 有多少名员工？▼

截至九月 04, 2026，公司共有162名员工。

Scpharmaceuticals 属于哪个行业？▼

Scpharmaceuticals从事于健康与养生行业。

Scpharmaceuticals 何时完成拆股？▼

Scpharmaceuticals 最近没有进行任何拆股。

Scpharmaceuticals 的总部在哪里？▼

Scpharmaceuticals 的总部位于美国的 Burlington。